Phase 3 trials for AstraZeneca's COVID-19 vaccine candidate were paused Tuesday due to a 'potentially unexplained illness in one of the trials.'
A company logo is seen on the outside of a building operated by biopharmaceutical company AstraZeneca.A late stage clinical trial for a potential COVID-19 vaccine was brought to a premature halt on Tuesday due to an unexplained and potentially serious illness experienced by a trial participant.
AstraZeneca said they had taken"routine action" in voluntarily pausing progress on trials for the vaccine, which was developed with researchers from the University of Oxford. The company began to recruit up to 30,000 U.S. participants for Phase 3 trials in late August, joining others already taking part in the U.K., Brazil and South Africa. "As part of the ongoing randomised, controlled global trials of the Oxford coronavirus vaccine, our standard review process was triggered and we voluntarily paused vaccination to allow review of safety data by an independent committee," an AstraZeneca spokesperson said in a statement obtained by"This is a routine action which has to happen whenever there is a potentially unexplained illness in one of the trials, while it is investigated, ensuring we maintain the integrity of the trials," the spokesperson added."In large trials illnesses will happen by chance but must be independently reviewed to check this carefully."to STAT News. However, the company has not confirmed details of the illness or where it occurred. The trial will resume if it is deemed safe to do so once the investigation is completed. "We are working to expedite the review of the single event to minimise any potential impact on the trial timeline," AstraZeneca said."We are committed to the safety of our participants and the highest standards of conduct in our trials."
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Pfizer and BioNTech approved to start phase 2/3 trial of Covid-19 vaccineA German regulatory authority has approved a phase 2/3 clinical trial in Germany of a Covid-19 vaccine candidate being developed by US pharmaceutical company Pfizer and German biotechnology company BioNTech
Read more »
Religious Leader Who Blamed Same-Sex Marriage For Covid Catches CovidPatriarch Filaret, who is the head of the Ukrainian Orthodox Church, was hospitalized last week having also developed pneumonia, congregation officials confirmed on Facebook.
Read more »
COVID vaccine candidate developed by Oxford University and AstraZeneca put on hold after 'unexplained illness'Drug giant AstraZeneca is reviewing the event that caused the illness during Phase 3 of Oxford's COVID-19 vaccine trials. The interruption represents the first major hiccup in what has been a smooth path in the rapid vaccine effort spanning the globe.
Read more »
AstraZeneca Pauses Covid-19 Vaccine Trial After Illness in a U.K. SubjectAstraZeneca said it paused clinical trials of an experimental Covid-19 vaccine after a participant in a U.K. study had an unexplained illness.
Read more »
COVID-19 Vaccine Trial Paused, Due To Illness In One VolunteerDrugmaker AstraZeneca says it's pausing its COVID-19 vaccine trial because of a 'potentially unexplained illness' in one of the trial volunteers. A safety review will be conducted to determine if it's a chance event or somehow related to the vaccine.
Read more »
AstraZeneca pauses Covid-19 vaccine trial – latest updatesA look at latest developments in global Covid-19 crisis👇: 💉 AstraZeneca suspends vaccine trial after one illness 🇬🇧 UK plans hiring spree to harness big data in virus recovery 🇧🇷 Brazil eyes vaccine rollout in January For more:
Read more »